Asian Journal of Pharmaceutical Sciences,
Journal Year:
2023,
Volume and Issue:
18(3), P. 100801 - 100801
Published: March 28, 2023
Colorectal
cancer
(CRC)
is
a
common
digestive
tract
tumor
worldwide.
Specific
microorganisms,
including
Fusobacterium
nucleatum
(F.
nucleatum)
and
Escherichia
coli
(E.
coli),
are
abundant
in
colonic
mucosa
can
promote
the
progression
malignancy.
Therefore,
therapeutic
strategy
proposed
to
deliver
effective
drugs
colorectum
for
both
anticancer
antibacteria.
Here
we
used
thin-film
dispersion
method
encapsulate
hemiprotonic
phenanthroline-phenanthroline+
(ph-ph+)
into
nanomicelle.
The
results
showed
that
drug-loading
nanomicelle
had
good
dispersion,
particle
size
was
about
28
nm.
In
vitro
assay
indicated
active
against
CRC-related
obligate
facultative
anaerobes.
human
CRC
cells,
could
effectively
inhibit
cell
proliferation
induce
apoptosis.
vivo
distribution
release
ph-ph+
mainly
colorectum.
model
mice,
significantly
reduced
number
volume,
decreased
bacteria
load
colorectal
inflammation.
Together,
study
identifies
ph-ph+nanomicelle
has
potential
apply
treating
CRC,
also
suggests
combined
with
antimicrobial
therapy
would
be
feasible
way
therapy.
Asian Journal of Pharmaceutical Sciences,
Journal Year:
2023,
Volume and Issue:
18(4), P. 100829 - 100829
Published: July 1, 2023
Current
antitumor
monotherapy
has
many
limitations,
highlighting
the
need
for
novel
synergistic
anticancer
strategies.
Ferroptosis
is
an
iron-dependent
form
of
nonapoptotic
cell
death
that
plays
a
pivotal
regulatory
role
in
tumorigenesis
and
treatment.
Photodynamic
therapy
(PDT)
causes
irreversible
chemical
damage
to
target
lesions
widely
used
therapy.
However,
PDT's
effectiveness
usually
hindered
by
several
obstacles,
such
as
hypoxia,
excess
glutathione
(GSH),
tumor
resistance.
improves
efficacy
PDT
increasing
oxygen
reactive
species
(ROS)
or
reducing
GSH
levels,
also
enhances
ferroptosis
induction
due
ROS
effect
microenvironment
(TME).
Strategies
based
on
nanoparticles
(NPs)
can
subtly
exploit
potential
synergy
PDT.
This
review
explores
recent
advances
current
challenges
landscape
underlying
mechanisms
regulating
PDT,
well
nano
delivery
system-mediated
activity.
These
include
polymers,
biomimetic
materials,
metal
organic
frameworks
(MOFs),
inorganics,
carrier-free
NPs.
Finally,
we
highlight
future
perspectives
this
emerging
paradigm
targeted
cancer
therapies.
Nano-Micro Letters,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: May 2, 2024
As
a
new
form
of
regulated
cell
death,
ferroptosis
has
unraveled
the
unsolicited
theory
intrinsic
apoptosis
resistance
by
cancer
cells.
The
molecular
mechanism
depends
on
induction
oxidative
stress
through
excessive
reactive
oxygen
species
accumulation
and
glutathione
depletion
to
damage
structural
integrity
Due
their
high
loading
tunability,
nanocarriers
can
escort
delivery
ferro-therapeutics
desired
site
enhanced
permeation
or
retention
effect
active
targeting.
This
review
shed
light
necessity
iron
in
growth
fascinating
features
regulating
cycle
metastasis.
Additionally,
we
discussed
ferroptosis-mediated
therapy
using
nanoplatforms
chemical
basis
overcoming
barriers
therapy.
Asian Journal of Pharmaceutical Sciences,
Journal Year:
2023,
Volume and Issue:
18(6), P. 100874 - 100874
Published: Nov. 1, 2023
Hepatocellular
carcinoma
(HCC)
is
one
of
most
common
and
deadliest
malignancies.
Celastrol
(Cel),
a
natural
product
derived
from
the
Tripterygium
wilfordii
plant,
has
been
extensively
researched
for
its
potential
effectiveness
in
fighting
cancer.
However,
clinical
application
hindered
by
unclear
mechanism
action.
Here,
we
used
chemical
proteomics
to
identify
direct
targets
Cel
enhanced
targetability
anti-tumor
capacity
developing
Cel-based
liposomes
HCC.
We
demonstrated
that
selectively
voltage-dependent
anion
channel
2
(VDAC2).
directly
binds
cysteine
residues
VDAC2,
induces
cytochrome
C
release
via
dysregulating
VDAC2-mediated
mitochondrial
permeability
transition
pore
(mPTP)
function.
further
found
ROS-mediated
ferroptosis
apoptosis
HCC
cells.
Moreover,
coencapsulation
into
alkyl
glucoside-modified
(AGCL)
improved
antitumor
efficacy
minimized
side
effects.
AGCL
shown
effectively
suppress
proliferation
tumor
In
xenograft
nude
mice
experiment,
significantly
inhibited
growth
promoted
apoptosis.
Our
findings
reveal
VDAC2
induce
mitochondria-dependent
cell
death,
while
enhance
reduces
Overall,
shows
promise
as
therapeutic
agent
Life Sciences,
Journal Year:
2024,
Volume and Issue:
346, P. 122629 - 122629
Published: April 15, 2024
Ferroptosis
is
a
novel
type
of
controlled
cell
death
resulting
from
an
imbalance
between
oxidative
harm
and
protective
mechanisms,
demonstrating
significant
potential
in
combating
cancer.
It
differs
other
forms
death,
such
as
apoptosis
necrosis.
Molecular
therapeutics
have
hard
time
playing
the
long-acting
role
ferroptosis
induction
due
to
their
limited
water
solubility,
low
targeting
capacity,
quick
metabolism
vivo.
To
this
end,
small
molecule
inducers
based
on
biological
factors
long
been
used
strategy
induce
death.
Research
into
advancements
nanotechnology
led
discovery
that
nanomaterials
are
superior
medications
triggering
ferroptosis.
Nanomaterials
derived
iron
can
enhance
by
directly
releasing
large
quantities
increasing
ROS
levels.
Moreover,
utilizing
promote
programmed
minimizes
probability
unfavorable
effects
induced
mutations
cancer-associated
genes
RAS
TP53.
Taken
together,
review
summarizes
molecular
mechanisms
involved
along
with
classification
induction.
also
emphasized
importance
organelles
control
cancer
therapy.
The
trigger
categorized
explained.
Iron-based
noniron-based
characterization
at
cellular
levels
explored,
which
will
be
useful
for
inducing
leads
reduced
tumor
growth.
Within
framework,
we
offer
synopsis,
traverses
well-established
mechanism
offers
practical
suggestions
design
therapeutic
use
nanomaterials.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(21), P. 5209 - 5209
Published: Oct. 30, 2023
Drug
resistance
remains
a
significant
challenge
in
the
treatment
of
colorectal
cancer
(CRC).
In
recent
years,
emerging
field
ferroptosis,
unique
form
regulated
cell
death
characterized
by
iron-dependent
lipid
peroxidation,
has
offered
new
insights
and
potential
therapeutic
strategies
for
overcoming
drug
CRC.
This
review
examines
role
ferroptosis
CRC
its
impact
on
resistance.
It
highlights
distinctive
features
advantages
compared
to
other
pathways,
such
as
apoptosis
necrosis.
Furthermore,
discusses
current
research
advances
field,
including
novel
approaches
that
target
ferroptosis.
These
involve
use
inducers,
interventions
iron
metabolism
combination
therapies
enhance
efficacy
The
also
explores
immunotherapy
modulating
strategy.
Additionally,
it
evaluates
strengths
limitations
targeting
selectivity,
low
side
effects,
overcome
resistance,
well
challenges
related
specificity
development.
Looking
future,
this
prospects
ferroptosis-based
CRC,
emphasizing
importance
further
elucidate
interaction
between
proposes
future
directions
more
effective
strategies,
development
approaches,
therapies,
integration
with
fields
precision
medicine.
conclusion,
harnessing
represents
promising
avenue
Continued
efforts
are
crucial
optimizing
outcomes
providing
hope
patients.
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: Feb. 23, 2023
The
brain
tumor
is
a
kind
of
malignant
with
brutal
treatment,
high
recurrence
rate,
and
poor
prognosis,
the
incidence
death
rate
increasing
yearly.
Surgery
often
used
to
remove
primary
tumor,
supplemented
by
radiotherapy
chemotherapy,
which
have
highly
toxic
side
effects.
Therefore,
there
an
urgent
need
explore
new
strategies,
methods,
technologies
that
can
genuinely
improve
treatment
tumors.
Ferroptosis
differs
from
traditional
apoptosis’s
morphological
biochemical
characteristics,
ferroptosis
possesses
its
unique
characteristics
mechanisms,
opening
up
field
for
cancer.
It
has
been
found
close
relationship
between
tumors,
novel
nano-drug
delivery
system
based
on
tumors
remarkable
This
review
firstly
analyzes
ferroptosis,
summarizes
mechanism
occurrence
some
factors
be
involved
in
regulation
introduces
potential
link
clarifies
feasibility
then
presents
nano
drug
systems
developed
under
different
metabolic
pathways
Finally,
it
current
problems
solutions
drugs
aiming
provide
reference
developing
against